It acts as a co-receptor by complexation with other transmembrane receptors such as VEGFR and plexin receptors, which are involved in neoangiogenesis and tumor progression by activating signaling pathways leading to cell survival, proliferation or migration [11]. The gene discussed is KDR; the disease is neoplasm.